The association between migrant status and transition in an ultra-high risk for psychosis population.


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 13 09 2019
accepted: 08 12 2020
pubmed: 6 1 2021
medline: 16 6 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

Migrant status is one of the most replicated and robust risk factors for developing a psychotic disorder. This study aimed to determine whether migrant status in people identified as Ultra-High Risk for Psychosis (UHR) was associated with risk of transitioning to a full-threshold psychotic disorder. Hazard ratios for the risk of transition were calculated from five large UHR cohorts (n = 2166) and were used to conduct a meta-analysis using the generic inverse-variance method using a random-effects model. 2166 UHR young people, with a mean age of 19.1 years (SD ± 4.5) were included, of whom 221 (10.7%) were first-generation migrants. A total of 357 young people transitioned to psychosis over a median follow-up time of 417 days (I.Q.R.147-756 days), representing 17.0% of the cohort. The risk of transition to a full-threshold disorder was not increased for first-generation migrants, (HR = 1.08, 95% CI 0.62-1.89); however, there was a high level of heterogeneity between studies The hazard ratio for second-generation migrants to transition to a full-threshold psychotic disorder compared to the remainder of the native-born population was 1.03 (95% CI 0.70-1.51). This meta-analysis did not find a statistically significant association between migrant status and an increased risk for transition to a full-threshold psychotic disorder; however, several methodological issues could explain this finding. Further research should focus on examining the risk of specific migrant groups and also ensuring that migrant populations are adequately represented within UHR clinics.

Identifiants

pubmed: 33399885
doi: 10.1007/s00127-020-02012-6
pii: 10.1007/s00127-020-02012-6
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

943-952

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH066069
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH082004
Pays : United States

Références

Cantor-Graae E, Selten J-P (2005) Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162(1):12–24. https://doi.org/10.1176/appi.ajp.162.1.12
doi: 10.1176/appi.ajp.162.1.12 pubmed: 15625195
Selten JP, van der Ven E, Termorshuizen F (2020) Migration and psychosis: a meta-analysis of incidence studies. Psychol Med 50(2):303–313. https://doi.org/10.1017/S0033291719000035
doi: 10.1017/S0033291719000035 pubmed: 30722795
Odegaard O (1932) Emigration and insanity: a study of mental disorders among Norwegian-born population in Minnesota. Acta Psychiatr Neurol Scand 4:1–206
Cantor Graae E, Pedersen C, McNeil T, Mortensen P (2003) Migration as a risk factor for schizophrenia: a Danish population-based cohort study. Br J Psychiatry 182:117–122
doi: 10.1192/bjp.182.2.117
Selten JP, Slaets JP, Kahn RS (1997) Schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands: evidence of an increased incidence. Psychol Med 27(4):807–811
doi: 10.1017/S0033291797005199
Smith GN, Boydell J, Murray RM, Flynn S, McKay K, Sherwood M, Honer WG (2006) The incidence of schizophrenia in European immigrants to Canada. Schizophr Res 87(1–3):205–211. https://doi.org/10.1016/j.schres.2006.06.024
doi: 10.1016/j.schres.2006.06.024 pubmed: 16905294
Tortelli A, Errazuriz A, Croudace T, Morgan C, Murray RM, Jones PB, Szoke A, Kirkbride JB (2015) Schizophrenia and other psychotic disorders in Caribbean-born migrants and their descendants in England: systematic review and meta-analysis of incidence rates, 1950–2013. Soc Psychiatry Psychiatr Epidemiol 50(7):1039–1055. https://doi.org/10.1007/s00127-015-1021-6
doi: 10.1007/s00127-015-1021-6 pubmed: 25660551 pmcid: 4464051
O’Donoghue B, Downey L, Eaton S, Mifsud N, Kirkbride JB, McGorry P (2020) Risk of psychotic disorders in migrants to Australia. Psychol Med. https://doi.org/10.1017/S0033291719004100
doi: 10.1017/S0033291719004100 pubmed: 31996272
Dykxhoorn J, Kirkbride JB (2019) Psychoses sans Frontieres: towards an interdisciplinary understanding of psychosis risk amongst migrants and their descendants. Epidemiol Psychiatr Sci 28(2):146–152. https://doi.org/10.1017/S2045796018000501
doi: 10.1017/S2045796018000501 pubmed: 30208980
Anderson KK, Edwards J (2020) Age at migration and the risk of psychotic disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 141(5):410–420. https://doi.org/10.1111/acps.13147
doi: 10.1111/acps.13147 pubmed: 31903545
Yung AR, Nelson B (2013) The ultra-high risk concept-a review. Can J Psychiatry 58(1):5–12. https://doi.org/10.1177/070674371305800103
doi: 10.1177/070674371305800103 pubmed: 23327750
Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996) Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 22(2):283–303
doi: 10.1093/schbul/22.2.283
Yung ARPL, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003) Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 60(1):21–32
doi: 10.1016/S0920-9964(02)00167-6
Yung ARPL, Yuen HP, McGorry PD (2003) Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 67(2):131–142
Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P (2012) Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69(3):220–229. https://doi.org/10.1001/archgenpsychiatry.2011.1472
doi: 10.1001/archgenpsychiatry.2011.1472 pubmed: 22393215
Addington J, Farris M, Stowkowy J, Santesteban-Echarri O, Metzak P, Kalathil MS (2019) Predictors of transition to psychosis in individuals at clinical high risk. Curr Psychiatry Rep 21(6):39. https://doi.org/10.1007/s11920-019-1027-y
doi: 10.1007/s11920-019-1027-y pubmed: 31037392
Geros H, Sizer H, Mifsud N, Reynolds S, Kim DJ, Eaton S, McGorry P, Nelson B, O’Donoghue B (2020) Migrant status and identification as ultra-high risk for psychosis and transitioning to a psychotic disorder. Acta Psychiatr Scand 141(1):52–59. https://doi.org/10.1111/acps.13099
doi: 10.1111/acps.13099 pubmed: 31520527
O’Donoghue B, Nelson B, Yuen HP, Lane A, Wood S, Thompson A, Lin A, McGorry P, Yung AR (2015) Social environmental risk factors for transition to psychosis in an ultra-high risk population. Schizophr Res 161(2–3):150–155. https://doi.org/10.1016/j.schres.2014.10.050
doi: 10.1016/j.schres.2014.10.050 pubmed: 25439392
Ising HK, Kraan TC, Rietdijk J, Dragt S, Klaassen RM, Boonstra N, Nieman DH, Willebrands-Mendrik M, van den Berg DP, Linszen DH, Wunderink L, Veling W, Smit F, van der Gaag M (2016) Four-year follow-up of cognitive behavioral therapy in persons at ultra-high risk for developing psychosis: the dutch early detection intervention evaluation (EDIE-NL) trial. Schizophr Bull 42(5):1243–1252. https://doi.org/10.1093/schbul/sbw018
doi: 10.1093/schbul/sbw018 pubmed: 26994397 pmcid: 4988735
Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH (2015) North American prodrome longitudinal study (NAPLS 2): the prodromal symptoms. J Nerv Ment Dis 203(5):328–335. https://doi.org/10.1097/NMD.0000000000000290
doi: 10.1097/NMD.0000000000000290 pubmed: 25919383 pmcid: 4417745
McGorry PD, Nelson B, Markulev C, Yuen HP, Schafer MR, Mossaheb N, Schlogelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rossler A, Verma S, Thompson A, Yung AR, Amminger GP (2017) Effect of omega-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial. JAMA Psychiatry 74(1):19–27. https://doi.org/10.1001/jamapsychiatry.2016.2902
doi: 10.1001/jamapsychiatry.2016.2902 pubmed: 27893018
Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewer WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR (2013) Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 70(8):793–802. https://doi.org/10.1001/jamapsychiatry.2013.1270
doi: 10.1001/jamapsychiatry.2013.1270 pubmed: 23739772
Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39(11–12):964–971. https://doi.org/10.1080/j.1440-1614.2005.01714.x
doi: 10.1080/j.1440-1614.2005.01714.x pubmed: 16343296
MacGlashan TW, Walsh BC, Woods SW (2010) The psychosis risk syndrome: handbook for diagnosis and follow-up. Oxford University Press, New York
Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW (2003) Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29(4):703–715. https://doi.org/10.1093/oxfordjournals.schbul.a007040
doi: 10.1093/oxfordjournals.schbul.a007040 pubmed: 14989408
IBM Corporation (2019) IBM SPSS Statistics for Windows Version 26.0. Armonk, NY
The_Cochrane-Collaboration (2020) Review Manager (Rev Man) 5.4 edn
Boonstra N, Sterk B, Wunderink L, Sytema S, De Haan L, Wiersma D (2012) Association of treatment delay, migration and urbanicity in psychosis. Eur Psychiatry J Assoc Eur Psychiatr 27(7):500–505. https://doi.org/10.1016/j.eurpsy.2011.05.001
doi: 10.1016/j.eurpsy.2011.05.001
Dapunt J, Kluge U, Heinz A (2017) Risk of psychosis in refugees: a literature review. Translational psychiatry 7(6):e1149–e1149. https://doi.org/10.1038/tp.2017.119
doi: 10.1038/tp.2017.119 pubmed: 28608852 pmcid: 5537641
van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L (2009) A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 39(2):179–195. https://doi.org/10.1017/S0033291708003814
doi: 10.1017/S0033291708003814 pubmed: 18606047
Scott J, Chant D, Andrews G, McGrath J (2006) Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychol Med 36(2):231–238. https://doi.org/10.1017/S0033291705006392
doi: 10.1017/S0033291705006392 pubmed: 16303059
Tarricone I, Atti AR, Salvatori F, Braca M, Ferrari S, Malmusi D, Berardi D (2009) Psychotic symptoms and general health in a socially disadvantaged migrant community in Bologna. Int J Soc Psychiatry 55(3):203–213. https://doi.org/10.1177/0020764008093445
doi: 10.1177/0020764008093445 pubmed: 19383664
King M, Nazroo J, Weich S, McKenzie K, Bhui K, Karlsen S, Stansfeld S, Tyrer P, Blanchard M, Lloyd K, McManus S, Sproston K, Erens B (2005) Psychotic symptoms in the general population of England–a comparison of ethnic groups (The EMPIRIC study). Soc Psychiatry Psychiatr Epidemiol 40(5):375–381
doi: 10.1007/s00127-005-0900-7
Nelson B, Yuen K, Yung AR (2011) Ultra high risk (UHR) for psychosis criteria: Are there different levels of risk for transition to psychosis? Schizophr Res 125(1):62–68. https://doi.org/10.1016/j.schres.2010.10.017
doi: 10.1016/j.schres.2010.10.017 pubmed: 21074975
Larsen TK, McGlashan TH, Moe LC (1996) First-episode schizophrenia: I. Early course parameters. Schizophr Bull 22(2):241–256
doi: 10.1093/schbul/22.2.241

Auteurs

Brian O'Donoghue (B)

Orygen, Melbourne, Australia. brian.odonoghue@orygen.org.au.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia. brian.odonoghue@orygen.org.au.

Hellen Geros (H)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Holly Sizer (H)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Jean Addington (J)

Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

G Paul Amminger (GP)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.
Department of Psychiatry, Medical University of Vienna, Vienna, Austria.

Carrie E Beaden (CE)

Department of Psychiatry and Biobehavioral Sciences, UCLA, Los Angeles, CA, USA.

Kristin S Cadenhead (KS)

Department of Psychiatry, UCSD, San Diego, CA, USA.

Tyrone D Cannon (TD)

Department of Psychology, Yale University, New Haven, CT, USA.

Barbara A Cornblatt (BA)

Department of Psychiatry, Zucker Hillside Hospital, Long Island, NY, USA.

Gregor Emanuel Berger (GE)

Child and Adolescent Psychiatric Service of the Canton of Zurich, Zürich, Switzerland.

Eric Y H Chen (EYH)

Department of Psychiatry, University of Hong Kong, Pok Fu Lam, Hong Kong.

Lieuwe de Haan (L)

Department of Psychiatry, Academic Medical Center, Amsterdam, The Netherlands.

Jessica A Hartmann (JA)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Ian B Hickie (IB)

Brain and Mind Research Institute, University of Sydney, Sydney, Australia.

Helga K Ising (HK)

Department of Psychosis Research, Parnassia Psychiatric Institute, The Hague, The Netherlands.

Suzie Lavoie (S)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Ashleigh Lin (A)

Telethon Kids Institute, Perth, Australia.

Connie Markulev (C)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Daniel H Mathalon (DH)

Department of Psychiatry, UCSF, San Francisco, CA, USA.
SFVA Medical Center, San Francisco, CA, USA.

Thomas H McGlashan (TH)

Department of Psychiatry, Yale University, New Haven, CT, USA.

Nathan G Mifsud (NG)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Nilufar Mossaheb (N)

Department of Psychiatry, Medical University of Vienna, Vienna, Austria.

Dorien H Nieman (DH)

Department of Psychiatry, Academic Medical Center, Amsterdam, The Netherlands.

Merete Nordentoft (M)

Psychiatric Centre Bispebjerg, Copenhagen, Denmark.

Diana O Perkins (DO)

Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.

Anita Riecher-Rössler (A)

Psychiatric University Clinics Basel, Basel, Switzerland.

Miriam R Schäfer (MR)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Monika Schlögelhofer (M)

Department of Psychiatry, Medical University of Vienna, Vienna, Austria.

Larry J Seidman (LJ)

Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center, Boston, MA, USA.
Massachusetts General Hospital, Boston, MA, USA.

Stephan Smesny (S)

Department of Psychiatry, University Hospital Jena, Jena, Germany.

Andrew Thompson (A)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Ming T Tsuang (MT)

Department of Psychiatry, UCSD, San Diego, CA, USA.

Mark van der Gaag (M)

Department of Psychosis Research, Parnassia Psychiatric Institute, The Hague, The Netherlands.
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit , Amsterdam, The Netherlands.

Swapna Verma (S)

Institute of Mental Health, Singapore, Singapore.

Elaine F Walker (EF)

Department of Psychology, Emory University, Atlanta, GA, USA.

Stephen J Wood (SJ)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Scott W Woods (SW)

Department of Psychiatry, Yale University, New Haven, CT, USA.

Hok Pan Yuen (HP)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Alison Ruth Yung (AR)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.
Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, England.

Patrick D McGorry (PD)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Barnaby Nelson (B)

Orygen, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH